Posted by Michael Wonder on 14 Mar 2023
CEO’s appointment to HTA Review Reference Committee
15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on the Health Technology Assessment Review Reference Committee.
The appointment was made today by the Minister for Health and Aged Care, the Hon. Mark Butler MP, which recognises Ms de Somer’s understanding of the issues, extensive industry experience, willingness to work collaboratively with all interested stakeholders, and commitment to reforming health technology assessment in the best interest of all Australians.
